Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Earl-Clay Laboratories, Inc. — Predicate Candidate Screening
21 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
39 daysmedian FDA review time
50 days90th percentile
21clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K861585 | ULTRACLONE 01-2300 CELL LINE | Earl-Clay Laboratories, Inc. | 1986-05-13 | 14 | 0 |
| K861569 | ULTRACLONE 01-700 CELL LINE | Earl-Clay Laboratories, Inc. | 1986-05-05 | 7 | 0 |
| K854206 | ULTRACLONE 05-100 GUINEA PIG RBC | Earl-Clay Laboratories, Inc. | 1985-10-31 | 15 | 0 |
| K853203 | ULTRACLONE ECL-01-2200 CELL LINE | Earl-Clay Laboratories, Inc. | 1985-08-12 | 13 | 0 |
| K851545 | ULTRACLONE ECL-01-800 CELL LINE | Earl-Clay Laboratories, Inc. | 1985-05-10 | 24 | 0 |
| K843577 | ULTRAXLONE ECL-01-1000 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-10-31 | 50 | 0 |
| K843579 | ULTRACLONE ECL-01-1100 | Earl-Clay Laboratories, Inc. | 1984-10-31 | 50 | 0 |
| K843578 | ULTRACLONE ECL-01-2100 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-10-31 | 50 | 0 |
| K843862 | ULTRACLONE ECL-01-900 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-10-17 | 15 | 0 |
| K843863 | ULTRACLONE ECL-01-1300 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-10-17 | 15 | 0 |
| K843864 | ULTRACLONE ECL-01-1400 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-10-17 | 15 | 0 |
| K841337 | ULTRACLONE ECL-01-800 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841341 | ULTRACLONE ECL-01-1000 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841339 | ULTRA CLONE ECL-01-700 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841342 | ULTRACLONE ECL-01-400 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841343 | ULTRACLONE ECL-01-100 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841338 | ULTRACLONE ECL-01-600 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841346 | ULTRACLONE ECL-01-200 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841340 | ULTRACLONE ECL-01-900 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841345 | ULTRACLONE ECL-01-500 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
| K841344 | ULTRACLONE ECL-01-300 CELL LINE | Earl-Clay Laboratories, Inc. | 1984-05-11 | 39 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda